Girihlet

Girihlet

Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.

Girihlet’s T and B cell sequencing assays and immune map database allow predictions and measurements on a person’s health status and provide an un understanding of the immune system in order to treat cancer, allergies, infections and autoimmune disease.

Timeline

August 2018
Girihlet raises a $2,500,000 seed round from Digitalis Ventures and True Ventures.
September 2015
Girihlet raises a $250,000 seed round from IndieBio and SOSV.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Girihlet, Seed Round, September 2015
250,000
September 2015
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.